Early Data With Olaratumab in Soft Tissue Sarcoma
3 विचारों
administrator
07/18/23
The panelists, Brian Van Tine, MD, PhD; Shreyaskumar Patel, MD; Robin L. Jones, MD, MRCP; Jonathan Trent, MD, PhD; and Andrew Wagner, MD; discuss phase I/II data with olaratumab and its mechanism of action.
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली